Sally Beauty Holdings, Inc. (NYSE:SBH)
Sally Beauty Holdings, Inc. (NYSE:SBH), ended its previous trading session at $10.24 showing a loss of -0.93 or -8.33 percent with respect to the price of $11.17 when stock market opened. The company traded 2.16 Million shares over the course of the trading day. Giving the average volume of 2.26 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 112.27 Million.
Sally Beauty Holdings, Inc. (NYSE:SBH) is currently trading lower than its price target which is set to $13 by the analyst. The stock is -46.75% Below its 1-Year High which is $19.23. SBH has a difference of 63.06% from its 1 year low which stands at $6.28. The company is currently rated by analyst who are keeping a close eye on the stock as 3.1. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
Sally Beauty Holdings, Inc. (NYSE:SBH) Performance Snapshot
The stock performed exceptionally bad in the previous week which depicts an decrease of -5.36 percent in the shares price. The company added about 10.58% in its share price over 1-Month. While taking about the performance of the stock over 1-year interval is -45.15 Percent. SBH currently shows -43.89% as its year to date performance.
Sally Beauty Holdings, Inc. (NYSE:SBH) Price Insight
The stock needs to grow about $2.76 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 7.22%, 5.31% and -8.41 percent respectively. The stock trades about 20.22 percent of its Float giving its total shares Outstanding are 112.27 Million. SBH lost about -10.88 percent in 6 months showing its Average True Range of 0.61. The company currently has a RSI and Beta of 53.45 and 1.32.
While talking about Sally Beauty Holdings, Inc. (NYSE:SBH) valuation ratios, the stock trades with a P/S and P/B of 0.31 and 0 which is significantly better and attractive as compared to its peers.
RXi Pharmaceuticals Corporation (NASDAQ:RXII)
Performance Indicators of RXi Pharmaceuticals Corporation (NASDAQ:RXII)
RXi Pharmaceuticals Corporation (NASDAQ:RXII) Analytical Review